90/014,962METHODS FOR PRODUCING PIEZOELECTRIC BULK AND CRYSTALLINE SEED LAYERS OF DIFFERENT C-AXIS ORIENTATION DISTRIBUTIONS10,063,210Closed

Status

Request for Reexamination Denied

Filed

Feb 22, 2022

Last Updated

Mar 31, 2022

Art Unit

3991

Requester (Patent Owner)Inferred

Qorvo Biotechnologies LLC

Requested By

Patent Owner

P.O. Law Firm

MRG

Sector (CPC)

HElectrical & Electronic
H03Electronic Circuits
H03HImpedance Networks & Filters

USPC

204Chemistry: Electrical And Wave Energy

Reexam History (27 events)

Apr 19, 2022NRX.Notice of Reexam Published in Official Gazette
Mar 31, 2022MREXDRX - Mail Ex Parte Request for Reexamination Denied
Mar 17, 2022IDSCInformation Disclosure Statement considered
Mar 17, 2022IDSCInformation Disclosure Statement considered
Mar 17, 2022IDSCInformation Disclosure Statement considered
Mar 16, 2022MRPWPRX - Mail Pilot Waiver Program - Ex Parte Interview Summary
Mar 1, 2022DOCKCase Docketed to Examiner in GAU
Feb 25, 2022MRXNReexamination Formalities Notice Mailed
Feb 25, 2022MRXNReexamination Formalities Notice Mailed
Feb 24, 2022RXTTLRPTTitle Report
Feb 24, 2022RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Feb 24, 2022RXNREQFDNotice of reexamination request filing date
Feb 24, 2022RXNREQAUNotice of assignment of reexamination request
Feb 24, 2022FTFSFITF set to YES - revise initial setting
Feb 23, 2022WIDSInformation Disclosure Statement (IDS) Filed
Feb 23, 2022WIDSInformation Disclosure Statement (IDS) Filed
Feb 23, 2022RXLITSRReexam Litigation Search Conducted
Feb 22, 2022WIDSInformation Disclosure Statement (IDS) Filed
Feb 22, 2022WIDSInformation Disclosure Statement (IDS) Filed
Feb 22, 2022WIDSInformation Disclosure Statement (IDS) Filed
Feb 22, 2022WIDSInformation Disclosure Statement (IDS) Filed
Feb 22, 2022WIDSInformation Disclosure Statement (IDS) Filed
Feb 22, 2022RXOSUBReceipt of Original Ex Parte Reexam Request
Feb 22, 2022RXO_40Receipt of Orig. Ex Parte Reexam Request Less Than 40 Pages-Rule 1.20(c )(1)
Feb 22, 2022RXIDS.Information Disclosure Statement Filed
Feb 22, 2022RXIDS.Information Disclosure Statement Filed
Feb 22, 2022BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

None found

Federal Circuit (CAFC)

None found

Terminal Disclaimer

Filed — ApprovedApr 5, 2018

Prosecution History

DateCodeDescription
Apr 6, 2018P574PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Apr 5, 2018DISTTerminal Disclaimer Filed

Maintenance Fees

Grant
Aug 28, 2018
3.5-yr
Feb 28, 2022
Paid Feb 28, 2022
7.5-yr
Feb 28, 2026
Paid Jan 22, 2026
11.5-yr
Feb 28, 2030
Expiry
Nov 29, 2036

Entity Status

Large Entity

Expires

Nov 29, 2036 (10.7 yr remaining)

Term Adjustment

+47 days (~0.1 yr)

Assignments

2017201820192020202120222023FiledKEVIN MCCARRONJOHN BELSICKQORVO US, INC.QORVO BIOTECHNOLOGIES, LLCQORVO US, INC.
AssignmentReel/Frame: 040174/0554Recorded: Oct 31, 2016

From

JOHN BELSICKInventor
Oct 12, 2016
KEVIN MCCARRONInventor
Oct 11, 2016

To

QORVO US, INC.

AssignmentReel/Frame: 040010/0802Recorded: Oct 13, 2016

From

JOHN BELSICKInventor
Oct 12, 2016
KEVIN MCCARRONInventor
Oct 11, 2016

To

QORVO US, INC.

AssignmentReel/Frame: 047794/0087Recorded: Dec 12, 2018

From

QORVO US, INC.
Dec 4, 2018

To

QORVO BIOTECHNOLOGIES, LLC

AssignmentReel/Frame: 065124/0556Recorded: Oct 4, 2023

From

QORVO BIOTECHNOLOGIES, LLC
Oct 2, 2023

To

QORVO US, INC.